ConductScience.org, home

Paper19095437

Individual patient data analysis to assess modifications to the RECIST criteria.

Bogaerts J and 9 others. Eur J Cancer, 2009. Cited by 162 papers, by iCite.

Cite this record

ConductScience Library. Individual patient data analysis to assess modifications to the RECIST criteria. Papers, record 19095437. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19095437

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Individual patient data analysis to assess modifications to the RECIST criteria.
PubMed
Journal
Eur J Cancer
PubMed
Year
2009
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
162
iCite
Relative citation ratio, by iCite
4.04
iCite
Revised in PubMed
2024-12-19
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bogaerts JJan
2Ford RRobert
3Sargent DDan
4Schwartz LHLawrence H
5Rubinstein LLarry
6Lacombe DDenis
7Eisenhauer EElizabeth
8Verweij JJaap
9Therasse PPatrick
10RECIST Working PartyGroup

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NeoplasmsMajor topic
Practice Guidelines as TopicMajor topic
Statistics as TopicMajor topic
Clinical Trials as Topic
Databases, Bibliographic
Disease Progression
Disease-Free Survival
Humans
Medical Records Systems, Computerized
Treatment Outcome

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT02448589An Investigation of TAS-119 MonotherapyBackground

Source ClinicalTrials.gov

Download CSV of trials

Cited by98

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 162 citations.

PMIDTitleJournalYearIn PapersSource
42588656Deep Learning Quality Control for RECIST-Oriented Assessment: A Vision Transformer Predicts Inter-Reader Variability of Unidimensional Lesion Measurements on Contrast CT.Cancers (Basel)2026https://conductscience.org/library/papers/42588656PubMed
42403716Modified sini powder for the management of postoperative depression in non-small cell lung cancer patients: a multicenter, randomized, double-blind, placebo-controlled trial protocol.Front Pharmacol2026https://conductscience.org/library/papers/42403716PubMed
40875521The legend of the response evaluation criteria in solid tumors: A historical overview.Cancer2025https://conductscience.org/library/papers/40875521PubMed
40535076Evaluating the tumor response assessment of modified-RECIST 1.1 in advance non-small cell lung cancer: a post-hoc analysis of 1,147 patients from the EAST-LC trial.Transl Lung Cancer Res2025https://conductscience.org/library/papers/40535076PubMed
40316348A phase I, open-label, multicentre, first-in-human study to evaluate safety, pharmacokinetics and efficacy of AMG 404, a PD-1 inhibitor, in patients with advanced solid tumours.BMJ Open2025https://conductscience.org/library/papers/40316348PubMed
39576456Development and external evaluation of a self-learning auto-segmentation model for Colorectal Cancer Liver Metastases Assessment (COALA).Insights Imaging2024https://conductscience.org/library/papers/39576456PubMed
39543673A call for objectivity: Radiologists' proposed wishlist for response evaluation in solid tumors (RECIST 1.1).Cancer Imaging2024https://conductscience.org/library/papers/39543673PubMed
39518034The Critical Role of Stereotactic Body Radiation Therapy in Multimodal Treatment of Lung Metastasis from Bone and Soft Tissue Sarcomas.Cancers (Basel)2024https://conductscience.org/library/papers/39518034PubMed
39114365CBX2 enhances the progression and TMZ chemoresistance of glioma via EZH2-mediated epigenetic silencing of PTEN expression.Front Pharmacol2024https://conductscience.org/library/papers/39114365PubMed
38779093
Efficacy of Shenglin decoction in preventing acute severe lymphocytopenia in patients with non-small cell lung cancer undergoing concurrent chemoradiotherapy: a study protocol for a randomized controlled trial.
Front Oncol2024https://conductscience.org/library/papers/38779093PubMed
38162847Impact of anticancer drugs on the therapeutic efficacy and side effects of hepatic arterial embolization for hepatocellular carcinoma.JGH Open2023https://conductscience.org/library/papers/38162847PubMed
37881238Tumor response assessment by measuring the single largest lesion per organ in advanced non-small cell lung cancer patients treated with PD-1/PD-L1 inhibitor.Ther Adv Med Oncol2023https://conductscience.org/library/papers/37881238PubMed
37720353Emerging role of quantitative imaging (radiomics) and artificial intelligence in precision oncology.Explor Target Antitumor Ther2023https://conductscience.org/library/papers/37720353PubMed
37614659Outcome of initial lenvatinib treatment in patients with unresectable anaplastic thyroid cancer.Oncol Lett2023https://conductscience.org/library/papers/37614659PubMed
37540134Discrepant Assessments of Progressive Disease in Clinical Trials between Routine Clinical Reads and Formal RECIST 1.1 Interpretations.Radiol Imaging Cancer2023https://conductscience.org/library/papers/37540134PubMed
37393537The role of clinical imaging in oncology drug development: progress and new challenges.Br J Radiol2023https://conductscience.org/library/papers/37393537PubMed
37223629Lesion Analysis in PERCIST 1.0: Clinical Ease versus Research Requisite-Where Does the Balance Exist?World J Nucl Med2023https://conductscience.org/library/papers/37223629PubMed
37073741Vincristine/irinotecan/temsirolimus upfront window treatment of high-risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 Study Committee.Pediatr Blood Cancer2023https://conductscience.org/library/papers/37073741PubMed
37011149FDA Oncology Center of Excellence Crowdsourcing Initiative: Outreach to the Scientific Community to Identify Research Questions for Pooled Analyses of Oncology Clinical Trial Data.Clin Cancer Res2023https://conductscience.org/library/papers/37011149PubMed
36940064Multicomponent mathematical model for tumor volume calculation with setup error using single-isocenter stereotactic radiotherapy for multiple brain metastases.Phys Eng Sci Med2023https://conductscience.org/library/papers/36940064PubMed

See all 98 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/19095437

GET https://conductscience.org/api/papers/v1/19095437/cited_by?page=2